Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ependymoma × fenofibric acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Medulloblastoma 1 Ependymoma 1

Interventions

Temozolomide 26 Magnetic Resonance Spectroscopy 16 Etoposide 13 Cyclophosphamide 13 Filgrastim 10 Radiotherapy 9 Carboplatin 9 Bevacizumab 9 Biopsy 8 X-Rays 6 Thiotepa 6 Specimen Handling 6 Phantoms, Imaging 6 Cisplatin 6 Nuclear Medicine Department, Hospital 5 Nivolumab 5 Irinotecan 5 Carmustine 5 sargramostim 4 Vincristine 4 Radiation 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 Erlotinib Hydrochloride 4 etoposide phosphate 3 Surveys and Questionnaires 3 Lapatinib 3 Granulocyte Colony-Stimulating Factor 3 Gadolinium DTPA 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡